Physician

Abbas Bitar, M.D

According to 2025 Medicare claims, Abbas Bitar, M.D (NPI: 1174836928) practices cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1891205969; TIN: 386006309) and primary practice location at 48109-5000. Bitar is affiliated with the POM ACO (ACO ID: A1297), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Bitar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 289 traditional Medicare patients, billed 817 HCPCS/CPT codes, and received $54,897 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,616 prescription claims across 526 beneficiaries totaling $1,468,656 in drug costs, led by Galafold (Migalastat Hcl). DME data shows 71 claims. Open Payments data shows 6 records totaling $44,748. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,845 to $1,468,656. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	165	439	$28,399
2018	358	1,413	$95,431
2019	365	1,477	$102,158
2020	353	1,054	$72,435
2021	358	1,156	$84,667
2022	358	1,107	$78,278
2023	377	963	$75,786
2024	289	817	$54,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	87	$4,845
2016	55	167	$10,171
2017	149	581	$46,337
2018	213	1,363	$101,135
2019	248	1,660	$165,596
2020	321	2,401	$278,542
2021	374	3,105	$395,428
2022	434	3,636	$883,421
2023	494	4,017	$1,470,799
2024	526	4,616	$1,468,656

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	42	$2,233
2020	N/R	91	$27,552
2021	N/R	105	$2,812
2022	N/R	112	$2,939
2023	N/R	94	$2,122
2024	N/R	71	$1,466

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	140	162	$104
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	34	164	$95
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	34	34	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	149	165	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	93	97	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Galafold	Migalastat Hcl	12	336	$359,421
Eliquis	Apixaban	255	16,871	$312,247
Jardiance	Empagliflozin	184	14,672	$268,231
Entresto	Sacubitril/Valsartan	110	5,794	$124,808
Farxiga	Dapagliflozin Propanediol	120	6,425	$116,273

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	21	$609
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	13	$318
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	20	$276
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	17	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$44	PROCYRION, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$44,704	PROCYRION, INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abbas Bitar, M.D?

Tedicare shows public-source Medicare data for Abbas Bitar, M.D (NPI 1174836928), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abbas Bitar, M.D have ACO affiliation data?

Abbas Bitar, M.D is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Abbas Bitar, M.D?

Abbas Bitar, M.D is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1891205969) in the available physician profile data.

Does Abbas Bitar, M.D have Open Payments data?

Abbas Bitar, M.D has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.